Clinical Trial Update: Tumor Suppressor Status as a Predictor of Chemotherapy Response in Triple Negative Breast Cancer

View source ↗

Summary

This clinical trial investigates whether tumor suppressor gene status can predict chemotherapy response in triple-negative breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Snippet

Sponsor: Thomas Jefferson University | Conditions: Breast Cancer | Status: UNKNOWN